COLLABORATION

Lexington Clinic Partners with Agilon Health to Transform Health Care

Agilon Health Inc. and Lexington Clinic have

Read the complete post announced their new partnership in order to change the primary care delivery system at Lexington Clinic to a full-risk, value-based care approach.

This transformation will improve the results and standard of treatment for Medicare patients in Central Kentucky beginning in 2024.

This new collaboration with Lexington Clinic highlights the increasing desire among primary care doctors to switch to a model of care for their Medicare patients that puts an emphasis on quality and outcomes.

As a new partner group for 2024, Lexington Clinic will be a part of Agilon's growing network of physician partners. Agilon's aligned alliances, purpose-built platform, and peer network of like-minded physicians are accelerating at scale the shift to a value-based, Total Care Model for senior patients.

Read the complete post

Read the complete post

Product Launch

Cardio Diagnostics Holdings Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

A combined epigenetic-genetic blood test for the early detection of coronary heart disease, PrecisionCHD™, has been launched by Cardio Diagnostics Holdings.

The second clinical test created by Cardio Diagnostics' in-house AI-driven Combined Epigenetic-Genetic Engine is the PrecisionCHD.

PrecisionCHD uses genetic (single nucleotide polymorphism) and epigenetic (DNA methylation) biomarkers as well as a proprietary machine-learning model developed by analyzing billions of genomic and epigenomic data points to detect coronary heart disease with better than 75% sensitivity in both men and women.

The Actionable Clinical Intelligence tool that comes with PrecisionCHD maps a patient's individual biomarker profile onto modifiable risk factors like smoking, diabetes, hypertension, and hypercholesterolemia, which are considered to be major drivers to coronary heart disease.

The non-invasive, simple test gives medical professionals an alternative to conventional CHD diagnostic methods and offers a detailed, personalized patient report on the state of their CHD.

Partnership

Asensus Surgical Collaborate With Google Cloud to Advance Performance-Guided Surgery

Read the complete post

Asensus Surgical has disclosed a multi-year partnership with Google Cloud to incorporate the latter's secure cloud data architecture and machine learning (ML) technologies and to further develop the PerformanceGuided Surgery™ (PGS) framework, which is made possible by the Intelligent Surgical Unit™ (ISUTM) of Asensus Surgical.

Performance-Guided Surgery can assist surgeons in carrying out operations more precisely and quickly, eventually assisting surgeons in avoiding complications and enhancing patient outcomes.

The ISU is a platform for real-time intraoperative surgical image analytics that uses augmented intelligence to help lower surgical variability and offers tools to lessen a surgeon's cognitive fatigue while gathering clinical information about the surgical process. For doctors and hospitals, Asensus will allow patient access portals and performance dashboards, and Google Cloud's secure cloud data architecture will collect this information.

Asensus will use Google Cloud's machine learning technologies to analyze the data and derive clinical intelligence that can be used by hospitals and surgeons along with constantly enhancing the software in the ISU to provide better intra-operative clinical insight.

Acquisition

Olympus to Acquire Taewoong Medical for US $370 million

Olympus Corporation has agreed to purchase Taewoong Medical, a medical device business with its headquarters in Korea for a total of about US $370 million in cash.

Taewoong produces medical devices like gastrointestinal (GI) metallic stents, which aid in removing obstructions or strictures brought on by cancer or other illnesses.

The Korean medical device manufacturer will receive up to US $114.5 million in potential future milestone payments in addition to US $255.5 million at closing under the terms of the deal.

The deal is anticipated to close by June 30, 2023, subject to certain customary closing conditions.

The biliary system, oesophagus, colon, and duodenum can all be treated with the help of Taewoong's assortment of medical devices, which also includes metallic GI stents.

Strong radial force and high flexibility are said to be combined in its metallic stents, allowing them to adapt to the curve of anatomical structures like biliary tracts and the oesophagus.

Taewoong provides a wide selection of premium stents with distinctive design and technological capabilities to help medical professionals using minimally invasive procedures.

With the acquisition, the company expands its product line to include Taewoong's medical devices, making it a complete market supplier of several GI solutions.

Collaboration

Canon Medical Partners with Tribun Health to Include Pathology

Through its collaboration with Tribun Health, Canon

Medical Informatics has expanded the Enterprise Imaging (EI) suite of products to include pathology.

As part of their precision informatics roadmaps, this gives healthcare companies new capability to effectively integrate pathology into their enterprise imaging plans.

Canon Medical offers healthcare companies an allin-one suite of choices and a single comprehensive partnership for their most imaging-intensive departments, including radiology, cardiology, endoscopy, and now pathology.

Canon Medical’s EI suite combines disease-centric solutions to promote sub-specialty collaboration. Tribun Health’s KLAS-leading CaloPix solution was the perfect intelligent extension with same cultural fit to Canon Medical and its solutions and services.

Some of the biggest, most complicated, and dynamic companies in the world are powered by Canon Medical solutions.

Read the complete post